A family-based association analysis and meta-analysis of the reading disabilities candidate gene DYX1C1.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 23341075)

Published in Am J Med Genet B Neuropsychiatr Genet on January 22, 2013

Authors

C Tran1, F Gagnon, K G Wigg, Y Feng, L Gomez, T D Cate-Carter, E N Kerr, L L Field, B J Kaplan, M W Lovett, C L Barr

Author Affiliations

1: Genetics and Development Division, Toronto Western Research Institute, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.

Articles cited by this

Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91

Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (2004) 125.23

Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24

Quantifying heterogeneity in a meta-analysis. Stat Med (2002) 83.16

A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res (1988) 77.80

Merlin--rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet (2001) 53.16

Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics (2003) 17.92

Replication validity of genetic association studies. Nat Genet (2001) 16.30

A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet (2004) 14.76

Implementing a unified approach to family-based tests of association. Genet Epidemiol (2000) 10.96

Dyslexia. N Engl J Med (1998) 5.51

Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol (2007) 4.96

Dyslexia: cultural diversity and biological unity. Science (2001) 4.17

Transmission/disequilibrium tests for extended marker haplotypes. Am J Hum Genet (1999) 4.07

Methods for meta-analysis in genetic association studies: a review of their potential and pitfalls. Hum Genet (2007) 3.92

Publication bias in meta-analysis: its causes and consequences. J Clin Epidemiol (2000) 3.70

Prevalence of reading disability in boys and girls. Results of the Connecticut Longitudinal Study. JAMA (1990) 3.41

Developmental dyslexia: four consecutive patients with cortical anomalies. Ann Neurol (1985) 3.30

Integrating case-control and TDT studies. Ann Hum Genet (2005) 3.19

Incidence of reading disability in a population-based birth cohort, 1976-1982, Rochester, Minn. Mayo Clin Proc (2001) 3.18

Rapid "automatized" naming (R.A.N): dyslexia differentiated from other learning disabilities. Neuropsychologia (1976) 3.00

Genetic influences on early word recognition abilities and disabilities: a study of 7-year-old twins. J Child Psychol Psychiatry (2005) 2.85

Susceptibility loci for distinct components of developmental dyslexia on chromosomes 6 and 15. Am J Hum Genet (1997) 2.65

Theories of developmental dyslexia: insights from a multiple case study of dyslexic adults. Brain (2003) 2.62

How meta-analysis increases statistical power. Psychol Methods (2003) 2.37

Genetic and environmental influences on orthographic and phonological skills in children with reading disabilities. Dev Neuropsychol (2001) 1.97

Developmental dyslexia: genetic dissection of a complex cognitive trait. Nat Rev Neurosci (2002) 1.97

A candidate gene for developmental dyslexia encodes a nuclear tetratricopeptide repeat domain protein dynamically regulated in brain. Proc Natl Acad Sci U S A (2003) 1.93

Evidence for a genetic aetiology in reading disability of twins. Nature (1987) 1.92

The neurological basis of developmental dyslexia: an overview and working hypothesis. Brain (2000) 1.81

Power and efficiency of the TDT and case-control design for association scans. Behav Genet (2002) 1.75

Quantitative trait locus association scan of early reading disability and ability using pooled DNA and 100K SNP microarrays in a sample of 5760 children. Mol Psychiatry (2007) 1.68

Investigation of dyslexia and SLI risk variants in reading- and language-impaired subjects. Behav Genet (2010) 1.67

Evidence for linkage of spelling disability to chromosome 15. Am J Hum Genet (1998) 1.65

Persistence of dyslexia: the Connecticut Longitudinal Study at adolescence. Pediatrics (1999) 1.64

Evaluation of the revised Ontario Child Health Study scales. J Child Psychol Psychiatry (1993) 1.54

Specific dyslexia (congenital word-blindness); a clinical and genetic study. Acta Psychiatr Neurol Suppl (1950) 1.52

DYX1C1 functions in neuronal migration in developing neocortex. Neuroscience (2006) 1.42

Developmental dyslexia in women: neuropathological findings in three patients. Ann Neurol (1990) 1.30

Support for EKN1 as the susceptibility locus for dyslexia on 15q21. Mol Psychiatry (2004) 1.29

Catmap: case-control and TDT meta-analysis package. BMC Bioinformatics (2008) 1.28

Disruption of neuronal migration by RNAi of Dyx1c1 results in neocortical and hippocampal malformations. Cereb Cortex (2007) 1.28

Developmental disruptions and behavioral impairments in rats following in utero RNAi of Dyx1c1. Brain Res Bull (2006) 1.27

Absence of linkage of phonological coding dyslexia to chromosome 6p23-p21.3 in a large family data set. Am J Hum Genet (1998) 1.24

Putative functional alleles of DYX1C1 are not associated with dyslexia susceptibility in a large sample of sibling pairs from the UK. J Med Genet (2004) 1.22

Evaluation of candidate genes for DYX1 and DYX2 in families with dyslexia. Am J Med Genet B Neuropsychiatr Genet (2007) 1.21

The genetics of specific reading disability. Ann Hum Genet (1976) 1.19

Evidence for major gene transmission of developmental dyslexia. JAMA (1991) 1.15

Children's Interview for Psychiatric Syndromes (ChIPS). J Am Acad Child Adolesc Psychiatry (2000) 1.15

Association of short-term memory with a variant within DYX1C1 in developmental dyslexia. Genes Brain Behav (2007) 1.13

Linkage analyses of four regions previously implicated in dyslexia: confirmation of a locus on chromosome 15q. Am J Med Genet B Neuropsychiatr Genet (2004) 1.12

A family-based association study does not support DYX1C1 on 15q21.3 as a candidate gene in developmental dyslexia. Eur J Hum Genet (2005) 1.11

Family-based association mapping provides evidence for a gene for reading disability on chromosome 15q. Hum Mol Genet (2000) 1.11

The complex of TFII-I, PARP1, and SFPQ proteins regulates the DYX1C1 gene implicated in neuronal migration and dyslexia. FASEB J (2008) 1.06

TDT-association analysis of EKN1 and dyslexia in a Colorado twin cohort. Hum Genet (2005) 1.06

Further evidence for DYX1C1 as a susceptibility factor for dyslexia. Psychiatr Genet (2009) 1.06

Association of reading disabilities with regions marked by acetylated H3 histones in KIAA0319. Am J Med Genet B Neuropsychiatr Genet (2010) 1.05

No evidence for association between dyslexia and DYX1C1 functional variants in a group of children and adolescents from Southern Italy. J Mol Neurosci (2005) 1.05

Analysis of dyslexia candidate genes in the Raine cohort representing the general Australian population. Genes Brain Behav (2010) 1.02

Dyslexia and DYX1C1: deficits in reading and spelling associated with a missense mutation. Mol Psychiatry (2009) 0.98

No support for association between dyslexia susceptibility 1 candidate 1 and developmental dyslexia. Mol Psychiatry (2005) 0.98

Confirmation of a dyslexia susceptibility locus on chromosome 1p34-p36 in a set of 100 Canadian families. Am J Med Genet B Neuropsychiatr Genet (2004) 0.98

Persistent spatial working memory deficits in rats following in utero RNAi of Dyx1c1. Genes Brain Behav (2010) 0.94

Differential genetic etiology of reading disability as a function of IQ. J Learn Disabil (2004) 0.90

A dyslexia susceptibility locus (DYX7) linked to dopamine D4 receptor (DRD4) region on chromosome 11p15.5. Am J Med Genet B Neuropsychiatr Genet (2004) 0.89

The genetic basis of dyslexia. Lancet Neurol (2002) 0.88

Genetic variation in the KIAA0319 5' region as a possible contributor to dyslexia. Behav Genet (2011) 0.88

Evidence for a susceptibility locus on chromosome 6q influencing phonological coding dyslexia. Am J Med Genet (2001) 0.84

Reading disability: evidence for a genetic etiology. Eur Child Adolesc Psychiatry (1999) 0.83

An examination of candidate gene SNPs for dyslexia in an Indian sample. Behav Genet (2011) 0.81

Allelic variants of DYX1C1 are not associated with dyslexia in India. Indian J Hum Genet (2008) 0.78

Further evidence for a susceptibility locus contributing to reading disability on chromosome 15q15-q21. Psychiatr Genet (2008) 0.77

Family history as an indicator of risk for reading disability. J Learn Disabil (1984) 0.76

Articles by these authors

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science (1996) 18.53

Highly pathogenic H5N1 influenza virus infection in migratory birds. Science (2005) 9.64

Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell (2001) 8.04

New real-time PCR assay for rapid detection of methicillin-resistant Staphylococcus aureus directly from specimens containing a mixture of staphylococci. J Clin Microbiol (2004) 6.06

HLA-DR effects in a large German IDDM dataset. Genet Epidemiol Suppl (1986) 5.41

Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet (2000) 4.57

Gene for hereditary retinoblastoma assigned to human chromosome 13 by linkage to esterase D. Science (1983) 4.43

Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. Gastroenterology (1998) 4.30

Mutations in filamin 1 prevent migration of cerebral cortical neurons in human periventricular heterotopia. Neuron (1998) 4.26

Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr (1997) 3.63

Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev (2000) 3.42

Mutations in the gene encoding gap junction protein beta-3 associated with autosomal dominant hearing impairment. Nat Genet (1998) 3.24

The fragile X mental retardation protein inhibits translation via interacting with mRNA. Nucleic Acids Res (2001) 3.18

Dapagliflozin, a novel, selective SGLT2 inhibitor, improved glycemic control over 2 weeks in patients with type 2 diabetes mellitus. Clin Pharmacol Ther (2009) 2.96

Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem Pharmacol (1996) 2.87

Rab11 is required for trans-golgi network-to-plasma membrane transport and a preferential target for GDP dissociation inhibitor. Mol Biol Cell (1998) 2.86

On avoiding dangerous anthropogenic interference with the climate system: formidable challenges ahead. Proc Natl Acad Sci U S A (2008) 2.82

Mutant Rab7 causes the accumulation of cathepsin D and cation-independent mannose 6-phosphate receptor in an early endocytic compartment. J Cell Biol (1998) 2.64

The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals. Hum Mol Genet (1996) 2.49

Linkage analysis of neurofibromatosis (von Recklinghausen disease). J Med Genet (1983) 2.13

Electric fish measure distance in the dark. Nature (1998) 2.11

Direct cell adhesion to the angiopoietins mediated by integrins. J Biol Chem (2001) 2.11

A hypervariable segment in the human dopamine receptor D4 (DRD4) gene. Hum Mol Genet (1993) 2.09

Recurrent mutations in a single exon encoding the evolutionarily conserved olfactomedin-homology domain of TIGR in familial open-angle glaucoma. Hum Mol Genet (1997) 2.08

Association mapping of disease loci, by use of a pooled DNA genomic screen. Am J Hum Genet (1997) 2.07

p53 protein expression in viral warts from patients with epidermodysplasia verruciformis. Br J Dermatol (1995) 2.04

X-ray and optical wave mixing. Nature (2012) 1.92

Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices. Circulation (2001) 1.91

Is lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study. J Am Coll Cardiol (1998) 1.88

A specific requirement for PDGF-C in palate formation and PDGFR-alpha signaling. Nat Genet (2004) 1.87

Retina and vitreous pathology after laser-assisted in situ keratomileusis: is there a cause-effect relationship? Ophthalmology (2001) 1.84

Differential regulation of HIV-1 fusion cofactor expression by CD28 costimulation of CD4+ T cells. Science (1997) 1.79

Effect of the arginine-82 to alanine mutation in bacteriorhodopsin on dark adaptation, proton release, and the photochemical cycle. Biochemistry (1993) 1.77

Generalized anxiety disorder: a preliminary test of a conceptual model. Behav Res Ther (1998) 1.76

Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases. Carcinogenesis (1993) 1.75

Anti-titin antibodies in myasthenia gravis: tight association with thymoma and heterogeneity of nonthymoma patients. Arch Neurol (2001) 1.73

Absolute pulse energy measurements of soft x-rays at the Linac Coherent Light Source. Opt Express (2014) 1.73

Phenotypic screening of small molecule libraries by high throughput cell imaging. Comb Chem High Throughput Screen (2003) 1.70

MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer. Oncogene (2012) 1.63

Purified recombinant Fmrp exhibits selective RNA binding as an intrinsic property of the fragile X mental retardation protein. J Biol Chem (1998) 1.63

Arctigenin, a natural compound, activates AMP-activated protein kinase via inhibition of mitochondria complex I and ameliorates metabolic disorders in ob/ob mice. Diabetologia (2011) 1.63

Polo-like kinase is required for the fragmentation of pericentriolar Golgi stacks during mitosis. Proc Natl Acad Sci U S A (2001) 1.59

Microbial metabolism of pyridine, quinoline, acridine, and their derivatives under aerobic and anaerobic conditions. Microbiol Rev (1996) 1.58

Blood Coagulation and Fibrinolysis in Relation to Coronary Heart Disease. Br Med J (1960) 1.57

Maternal uniparental disomy of chromosome 1 with no apparent phenotypic effects. Am J Hum Genet (1998) 1.57

Efficacy of a cognitive-behavioral treatment for generalized anxiety disorder: evaluation in a controlled clinical trial. J Consult Clin Psychol (2000) 1.55

The two pKa's of aspartate-85 and control of thermal isomerization and proton release in the arginine-82 to lysine mutant of bacteriorhodopsin. Biochemistry (1995) 1.52

Coaxial electrospinning of (fluorescein isothiocyanate-conjugated bovine serum albumin)-encapsulated poly(epsilon-caprolactone) nanofibers for sustained release. Biomacromolecules (2006) 1.51

Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt's lymphoma: a retrospective analysis. Ann Oncol (2011) 1.51

Propofol EC50 for inducing loss of consciousness is lower in the luteal phase of the menstrual cycle. Br J Anaesth (2013) 1.50

The regenerative effect of platelet-rich plasma on healing in large osteochondral defects. Int Orthop (2009) 1.49

Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens. Gut (2010) 1.47

Use of the Bruininks-Oseretsky test of motor proficiency in occupational therapy. Am J Occup Ther (1995) 1.46

Control of oxidation-reduction potentials in flavodoxin from Clostridium beijerinckii: the role of conformation changes. Biochemistry (1997) 1.45

Genome-wide association study of Tourette's syndrome. Mol Psychiatry (2012) 1.42

Isolation and partial characterization of novel genes encoding acidic cellulases from metagenomes of buffalo rumens. J Appl Microbiol (2009) 1.39

Dapagliflozin treatment in patients with different stages of type 2 diabetes mellitus: effects on glycaemic control and body weight. Diabetes Obes Metab (2010) 1.39

Undergraduate and postgraduate training programs for cytogenetic technologists. Am J Hum Genet (1988) 1.39

Repair of a palmar soft tissue defect of the proximal interphalangeal joint with a transposition flap from the dorsum of the proximal phalanx. J Hand Surg Eur Vol (2011) 1.39

Destabilization and mislocalization of myelin basic protein mRNAs in quaking dysmyelination lacking the QKI RNA-binding proteins. J Neurosci (2000) 1.38

Use of biomimetic diversity-oriented synthesis to discover galanthamine-like molecules with biological properties beyond those of the natural product. J Am Chem Soc (2001) 1.38

Rapid telomere shortening in children. Blood (1999) 1.35

Identification of DNA variants in the SNAP-25 gene and linkage study of these polymorphisms and attention-deficit hyperactivity disorder. Mol Psychiatry (2000) 1.31

Proton conduction and bafilomycin binding by the V0 domain of the coated vesicle V-ATPase. J Biol Chem (1994) 1.30

Close genetic linkage between diabetes mellitus and kidd blood group. Lancet (1981) 1.30

Support for EKN1 as the susceptibility locus for dyslexia on 15q21. Mol Psychiatry (2004) 1.29

Preventing tap water scalds: do consumers change their preset thermostats. Am J Public Health (1993) 1.29

Mechanical strain induces specific changes in the synthesis and organization of proteoglycans by vascular smooth muscle cells. J Biol Chem (2001) 1.29

Changes in fruit sugar concentrations in response to assimilate supply, metabolism and dilution: a modeling approach applied to peach fruit (Prunus persica). Tree Physiol (2003) 1.29

A mutation of the Drosophila sodium pump alpha subunit gene results in bang-sensitive paralysis. Neuron (1994) 1.26

Identification of enterohepatic Helicobacter species by restriction fragment-length polymorphism analysis of the 16S rRNA gene. Helicobacter (2000) 1.26

Coherence properties of individual femtosecond pulses of an x-ray free-electron laser. Phys Rev Lett (2011) 1.26

Coinfection of enteric Helicobacter spp. and Campylobacter spp. in cats. J Clin Microbiol (2001) 1.26

Association of the glutamate receptor subunit gene GRIN2B with attention-deficit/hyperactivity disorder. Genes Brain Behav (2006) 1.24

Overexpression of eotaxin and the CCR3 receptor in human atherosclerosis: using genomic technology to identify a potential novel pathway of vascular inflammation. Circulation (2000) 1.24

Absence of linkage of phonological coding dyslexia to chromosome 6p23-p21.3 in a large family data set. Am J Hum Genet (1998) 1.24

Cytoplasmic retention of HIV-1 regulatory protein Vpr by protein-protein interaction with a novel human cytoplasmic protein VprBP. Gene (2001) 1.22

The Tay-Sachs disease gene in North American Jewish populations: geographic variations and origin. Am J Hum Genet (1983) 1.22

Complications of laparoscopic cholecystectomy in China: an analysis of 39,238 cases. Chin Med J (Engl) (1997) 1.20

Extent and kinetics of recovery of occult spinal cord injury. Int J Radiat Oncol Biol Phys (2001) 1.20

Dynamic Data-Driven Finite Element Models for Laser Treatment of Cancer. Numer Methods Partial Differ Equ (2007) 1.19

Sticky traps for monitoring Pseudacteon parasitoids of Solenopsis fire ants. Environ Entomol (2007) 1.18

Reliability and validity of a parent questionnaire on childhood motor skills. Am J Occup Ther (2001) 1.17

Heterologous expression of a plant small heat-shock protein enhances Escherichia coli viability under heat and cold stress. Plant Physiol (1999) 1.17

Linkage of the dopamine receptor D1 gene to attention-deficit/hyperactivity disorder. Mol Psychiatry (2004) 1.16

Predicting DNA-binding proteins: approached from Chou's pseudo amino acid composition and other specific sequence features. Amino Acids (2007) 1.16

Efficacy and specificity of bFGF increased collateral flow in experimental peripheral arterial insufficiency. Am J Physiol Heart Circ Physiol (2000) 1.15

A designed peptidomimetic agonistic ligand of TrkA nerve growth factor receptors. Mol Pharmacol (2000) 1.15

Fumarate reductase is essential for Helicobacter pylori colonization of the mouse stomach. Microb Pathog (2000) 1.14

A comparison of structure-activity relationships between spermidine and spermine analogue antineoplastics. J Med Chem (1997) 1.13

Assessment of a superparamagnetic iron oxide (AMI-25) as a brain contrast agent. Magn Reson Med (1990) 1.13

A mechanism of resistance to HIV-1 entry: inefficient interactions of CXCR4 with CD4 and gp120 in macrophages. Virology (1999) 1.12

Development and laboratory evaluation of a new toothbrush with a novel brush head design. Am J Dent (2000) 1.12

Direct binding to nucleic acids by Vpr of human immunodeficiency virus type 1. Gene (1998) 1.12

Cognitive-behavioral treatment of obsessive thoughts: a controlled study. J Consult Clin Psychol (1997) 1.11

The SNAP25 gene as a susceptibility gene contributing to attention-deficit hyperactivity disorder. Mol Psychiatry (2005) 1.10